[Experience of the preventive use of the drug Riamilovir in the foci of coronavirus infection (COVID-19)].

Published in: Terapevticheskii arkhiv (2021)

The effectiveness and safety of the preventive use of the drug Riamilovir allow to recommend it for emergency drug prophylaxis in contact persons in the foci of a new coronavirus infection (COVID-19).

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
emergency department
adverse drug
public health
healthcare